iPS Cell Advanced Characterization and Development Team
-
Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiation
-
Dr. Ito received Young Investigator Award, and Dr. Chang and Mr. Shimizu received English Presentation Awards
-
Patient-derived and gene-edited pluripotent stem cells lacking NPHP1 recapitulate juvenile nephronophthisis in abnormalities of primary cilia and renal cyst formation
-
Dr. Yohei Hayashi resreved THE TCI VENTURE AWARD 2023 SEEDS DIVISON
-
Efficient selection of knocked-in pluripotent stem cells using a dual cassette cellular elimination system
-
Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes
-
In silico-labeled ghost cytometry
-
Structurally-discovered KLF4 variants accelerate and stabilize reprogramming to pluripotency
-
Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion